Clinical trial

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Questionnaire Administration Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Biospecimen Collection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2022-08-18

PhaseN/A

Conditions

Acute Lymphoblastic Leukemiaverified · MONDO: acute lymphoblastic leukemia

Acute Myeloid Leukemiaverified · MONDO: acute myeloid leukemia

Ann Arbor Stage I Lymphomaunresolved

Ann Arbor Stage II Lymphomaunresolved

Ann Arbor Stage III Lymphomaunresolved

Ann Arbor Stage IV Lymphomaunresolved

Chronic Lymphocytic Leukemiaverified · MONDO: B-cell chronic lymphocytic leukemia

Chronic Myeloid Leukemiaverified · MONDO: chronic myeloid leukemia

Gastroesophageal Junction Adenocarcinomaverified · MONDO: gastroesophageal junction adenocarcinoma

Head and Neck Carcinomaverified · MONDO: head and neck carcinoma

Hematopoietic and Lymphoid Cell Neoplasmverified · MONDO: hematopoietic and lymphoid cell neoplasm

Invasive Breast Carcinomaverified · MONDO: invasive breast carcinoma

Kidney Carcinomaverified · MONDO: renal carcinoma

Malignant Hepatobiliary Neoplasmunresolved

Malignant Solid Neoplasmunresolved

Melanomaverified · MONDO: melanoma

Muscle-Invasive Bladder Carcinomaunresolved

RISS Stage I Plasma Cell Myelomaunresolved

RISS Stage II Plasma Cell Myelomaunresolved

RISS Stage III Plasma Cell Myelomaunresolved

Sarcomaverified · MONDO: sarcoma

Stage I Bladder Cancer AJCC v6 and v7unresolved

Stage I Breast Cancer AJCC v7unresolved

Stage I Colorectal Cancer AJCC v6 and v7unresolved

Stage I Esophageal Cancer AJCC V7unresolved

Stage I Gastric Cancer AJCC V7unresolved

Stage I Lung Cancer AJCC v7unresolved

Stage I Ovarian Cancer AJCC v6 and v7unresolved

Stage I Pancreatic Cancer AJCC v6 and v7unresolved

Stage I Prostate Cancer AJCC v7unresolved

Stage I Uterine Corpus Cancer AJCC v7unresolved

Stage II Bladder Cancer AJCC v6 and v7unresolved

Stage II Breast Cancer AJCC v6 and v7unresolved

Stage II Colorectal Cancer AJCC v7unresolved

Stage II Esophageal Cancer AJCC v7unresolved

Stage II Gastric Cancer AJCC v7unresolved

Stage II Lung Cancer AJCC v7unresolved

Stage II Ovarian Cancer AJCC v6 and v7unresolved

Stage II Pancreatic Cancer AJCC v6 and v7unresolved

Stage II Prostate Cancer AJCC v7unresolved

Stage II Uterine Corpus Cancer AJCC v7unresolved

Stage III Bladder Cancer AJCC v6 and v7unresolved

Stage III Breast Cancer AJCC v7unresolved

Stage III Colorectal Cancer AJCC v7unresolved

Stage III Esophageal Cancer AJCC v7unresolved

Stage III Gastric Cancer AJCC v7unresolved

Stage III Lung Cancer AJCC v7unresolved

Stage III Ovarian Cancer AJCC v6 and v7unresolved

Stage III Pancreatic Cancer AJCC v6 and v7unresolved

Stage III Prostate Cancer AJCC v7unresolved

Stage III Uterine Corpus Cancer AJCC v7unresolved

Stage IV Bladder Cancer AJCC v7unresolved

Stage IV Breast Cancer AJCC v6 and v7unresolved

Stage IV Colorectal Cancer AJCC v7unresolved

Stage IV Esophageal Cancer AJCC v7unresolved

Stage IV Gastric Cancer AJCC v7unresolved

Stage IV Lung Cancer AJCC v7unresolved

Stage IV Ovarian Cancer AJCC v6 and v7unresolved

Stage IV Pancreatic Cancer AJCC v6 and v7unresolved

Stage IV Prostate Cancer AJCC v7unresolved

Stage IV Uterine Corpus Cancer AJCC v7unresolved

Thyroid Gland Carcinomaverified · MONDO: thyroid gland carcinoma

Interventions

Questionnaire AdministrationOTHER

Biospecimen CollectionPROCEDURE

Sponsors & collaborators

Alliance for Clinical Trials in Oncologylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Las VegasNevada, United States27 ColumbusOhio, United States8 DenverColorado, United States8 FargoNorth Dakota, United States6 Royal OakMichigan, United States6 ChicagoIllinois, United States5 CincinnatiOhio, United States5 Baton RougeLouisiana, United States5 St LouisMissouri, United States4 AuroraColorado, United States4 MilwaukeeWisconsin, United States4 AlbuquerqueNew Mexico, United States4

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05334069 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.